Connect your AI

Rollins ROL Proceeds from (repayments of) short-term borrowings, net

Proceeds from (repayments of) short-term borrowings, net at other companies

CVS HealthCVS

$0+100%

O'Reilly AutomotiveORLY

$815.78M+381%

Boston ScientificBSX

$0+100%

AmphenolAPH

$0-100%

Intercontinental ExchangeICE

$716M+846%

NWN

Northwest NaturalNWN

-$713K+99.2%

Other financials

Income statement

Revenue$1.1B+7.9%

Gross profit$569.9M+6.0%

Operating income$201.4M+1.5%

Net income$143.9M+1.7%

EPS (diluted)$0.30+3.4%

Balance sheet

Cash & equivalents$109.1M-11.3%

Total debt$628.2M+30.4%

Total equity$1.4B-1.0%

Total assets$3.4B+5.5%

Cash flow

Operating cash flow$172.5M-1.5%

CapEx$6.4M-9.1%

Free cash flow$166.1M-1.2%

Valuation

Market cap$18.64B-33.3%

Enterprise value$19.16B-32.3%

P/E35.1×-22.0×

P/S4.8×-3.1×

Profitability

Gross margin52.4%-0.3pp

Operating margin18.7%-0.5pp

Net margin13.6%-0.2pp

FCF margin15.8%-1.9pp

Returns & leverage

Return on equity37%+0.5pp

Debt / equity0.4×+0.1×

Current ratio0.6×-0.1×

Where this comes from

Reported directly by Rollins in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromRepaymentsOfCommercialPaper.

The official record: Rollins’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rollins's proceeds from (repayments of) short-term borrowings, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Rollins's proceeds from (repayments of) short-term borrowings, net?: Rollins (ROL) reported proceeds from (repayments of) short-term borrowings, net of $51.99M in Q2 2026.
How has Rollins's proceeds from (repayments of) short-term borrowings, net changed year-over-year?: Rollins's proceeds from (repayments of) short-term borrowings, net decreased by 13.3% year-over-year, from $59.99M to $51.99M.